Single dose bevacizumab as treatment for symptomatic, corticosteroid-refractory pseudoprogression after chemoradiation therapy for newly diagnosed glioblastoma A case report. Issue 4 (2015)

Record Type:: Journal Article
Title:: Single dose bevacizumab as treatment for symptomatic, corticosteroid-refractory pseudoprogression after chemoradiation therapy for newly diagnosed glioblastoma A case report. Issue 4 (2015)
Main Title:: Single dose bevacizumab as treatment for symptomatic, corticosteroid-refractory pseudoprogression after chemoradiation therapy for newly diagnosed glioblastoma A case report
Authors:: Vallieres, Taylor M. Morris. Isabelle
Attwell, Andrew
Tonseth, R Petter
Is Part Of:: Integrative cancer science and therapeutics. Volume 2:Issue 4(2015)
Journal:: Integrative cancer science and therapeutics
Issue:: Volume 2:Issue 4(2015)
Issue Display:: Volume 2, Issue 4 (2015)
Year:: 2015
Volume:: 2
Issue:: 4
Issue Sort Value:: 2015-0002-0004-0000
Page Start:
Page End:
Publication Date:: 2015
Subjects:: Cancer -- Periodicals
Cancer -- Treatment -- Periodicals
616.99406
Journal URLs:: http://www.oatext.com/IntegrativeCancerScienceandTherapeutics.php#About_Journal ↗
DOI:: 10.15761/ICST.1000141 ↗
Languages:: English
ISSNs:: 2056-4546
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 14271.xml